Hidoc Dr | Medical Learning App for Doctors

Today's Updates

Wnt/β-catenin in Multiple Sclerosis: A Nuanced Approach to Remyelination Kevin Chang, PharmD

Published Date: 31 Dec 2025

In this Neuropathways piece, Kevin Chang, PharmD, explores the complexities of remyelination in multiple sclerosis and the potential of Wnt/β-catenin signaling as a therapeutic target.

NeurologyLive® Brain Games: December 28, 2025 Marco Meglio, Louie Pasculli

Published Date: 31 Dec 2025

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on RBD as a prodromal marker for synucleinopathies!

Psoriatic Arthritis in 2025: Year in Review

Published Date: 31 Dec 2025

Psoriatic Arthritis in 2025: Year in Review

Reframing Fibromyalgia Care in 2025: Restricted Impact of TNX-102 SL’s Approval

Published Date: 31 Dec 2025

Reframing Fibromyalgia Care in 2025: Restricted Impact of TNX-102 SL’s Approval

Knowledge Hub

Oncology

Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides

Precision cancer care using theranostics and radioligand therapy enhances targeted treatment and patient outcomes.

Oncology

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization

Explore strategies for optimizing oncology trials, enhancing recruitment, decentralization, diversity, and patient-centered care.

Oncology

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies

Enhance cancer care with multidisciplinary strategies, supportive therapies, and patient-centered interventions for better outcomes.

Oncology

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies

Explore the future of cancer care with genetics, supportive strategies, and emerging therapies for patients.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Wnt/β-catenin in Multiple Sclerosis: A Nuanced Approach to Remyelination Kevin Chang, PharmD

NeurologyLive® Brain Games: December 28, 2025 Marco Meglio, Louie Pasculli

Psoriatic Arthritis in 2025: Year in Review

Reframing Fibromyalgia Care in 2025: Restricted Impact of TNX-102 SL’s Approval

Knowledge Hub

Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond

Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care

The Predictive Power of Targeted Radionuclide Therapy in Advanced Breast Cancer

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Wnt/β-catenin in Multiple Sclerosis: A Nuanced Approach to Remyelination Kevin Chang, PharmD

NeurologyLive® Brain Games: December 28, 2025 Marco Meglio, Louie Pasculli

Psoriatic Arthritis in 2025: Year in Review

Reframing Fibromyalgia Care in 2025: Restricted Impact of TNX-102 SL’s Approval

Knowledge Hub

Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond

Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care

The Predictive Power of Targeted Radionuclide Therapy in Advanced Breast Cancer

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views